<DOC>
	<DOCNO>NCT00929539</DOCNO>
	<brief_summary>The purpose study evaluate effect JTT-130 diabetes well safety tolerability JTT-130 obese Type 2 diabetic patient .</brief_summary>
	<brief_title>Safety Efficacy Study JTT-130 Obese Type 2 Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Have type 2 diabetes ; 2 . Body mass index ( BMI ) &gt; 27.0 kg/m2 ≤ 45.0 kg/m2 ; 3 . Are either drug naïve respect hypoglycemic agent OR currently treat metformin alone combination sulfonylurea . Metformin sulfonylurea dosing must stable . 1 . Females pregnant breastfeed 2 . Known medical history presence type 1 diabetes , pancreatitis , unstable rapidly progress retinopathy , nephropathy neuropathy ; 3 . Acute coronary syndrome uncontrolled hypertension ; 4 . Does meet medication restriction criterion , describe protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Diabetes</keyword>
</DOC>